Founder and CEO
|
Vice President, Products and Services
|
Scientific Advisor
|
|
|
|
co-founded Virtual Chemistry, Inc. (VCI) in November 1995. Terry holds degrees in computer science
and chemistry from the University of Illinois, and a Ph.D. in quantum computational
chemistry from Caltech.
At Deltagen, Dr. Coley served as the Vice President of Information Technology.
There he created standards for IT infrastructure, software development, and IT hiring practices.
Key accomplishments include the design and development of DeltaDiscovery, a flexible, metadata-driven system
for acquisition, warehousing, and web-display of laboratory data. This software hosted and
delivered all revenue-generating data for Deltagen's DeltaBase product, a subscription
database of functional genomics information.
Before establishing VCI, Dr. Coley founded a company in 1989 to sell a
load balancing system which he designed for parallel computers. In 1993,
Dr. Coley became a full-time consultant to Vestar, Inc. studying
molecular modeling approaches in their liposomal drug delivery group.
He joined Biosym Technologies in 1994 and became a Project Leader in the
life sciences business unit where he implemented the inter-process
communication facilities and designed the initial Message Passing
Interface-based parallelism in the Discover molecular dynamics program.
Dr. Coley has extensive experience in parallel computing, 3D computer
graphics, and software development tools and technologies. Dr. Coley is
directly involved with many projects at VCI.
|
joined Virtual Chemistry in August, 2003, bringing broad experience in
life sciences, software development, and engineering. Dr. Thelen joined
Virtual Chemistry from Deltagen, Inc. where he served as Group Leader
of Application Development. While at Deltagen, Dr. Thelen played a key
role in LIMS (laboratory information management systems) development,
data warehousing and data management implementations, and development of
Deltagen's functional genomics platform DeltaBase.
Dr. Thelen has consulted for such companies as: Gensym, TRW, BMC
Software, Atlantic Research Corporation, US Army LIA Labs, Computer
Sciences Corporation, US Air Force, and Ribozyme Pharmaceuticals.
Consulting engagements include such diverse applications as: Real-time
fault diagnosis (root-cause analysis) of distributed software and
network systems; dynamic scheduling, planning, and optimization
applications; business process modeling and re-engineering; laboratory
automation and integration applications; and knowledge management system
development.
Dr. Thelen did post-doctoral work with Dr. Robert L. Welch of Gensym
Corporation working on applications of Bayesian network technology to
fault diagnosis and real-time reliability analysis after receiving Ph.D.
and M.S. degrees in Chemical & Biological Engineering from the University of
Colorado, Boulder. Dr. Thelen also holds a B.S. in Chemical Engineering
from Michigan Technological University.
|
holds a degree in Biology from the University of Colorado.
After Post-Doctoral training at the Friedrich Miescher Institute in Basel, Switzerland
and the Biocenter at the University of Basel working on the regulation of protein synthesis,
he moved with Georges Koehler to the Max-Planck-Institute for Immunobiology and Epigenetics in Freiburg Germany
as a Research Group Leader and began working on gene expression during B-cell development.
During this time, he developed TierBase, a relational database to help scientists manage laboratory
animal breeding and experimentation. TierBase has become widely used in numerous European countries.
Peter has extensive experience translating the needs of animal management facility and scientific users into practical software.
In 2012, he started a collaboration with VCI to help develop a single product that will bring the
advantages of both Mosaic Vivarium and TierBase to user communities from North America to Europe and beyond.
|
|
